Founders to take part in Yale’s Innovation to Impact, Cohort 5!

Congratulations to our two Founders, Drs. Carry and Vasilatis, for being accepted into the prestigious Yale Innovation to Impact, cohort 5! They will be receiving entrepreneurial mentorship from a world-class teaching team specifically for innovation development in the substance use disorder space.

Previous
Previous

Zena Tx presents at NIDA Board of Directors Meeting

Next
Next

Zena founders attend the 2022 Bio International Convention in San Diego